|
ISY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27989849221899E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71509995094965E-09 |
| Normal-vs-Stage2 |
1.50360000006344E-07 |
| Normal-vs-Stage3 |
6.5754002243068E-10 |
| Normal-vs-Stage4 |
4.1315000309794E-09 |
| Stage1-vs-Stage2 |
1.353780E-01 |
| Stage1-vs-Stage3 |
1.576570E-01 |
| Stage1-vs-Stage4 |
2.203000E-01 |
| Stage2-vs-Stage3 |
6.499400E-01 |
| Stage2-vs-Stage4 |
7.767400E-01 |
| Stage3-vs-Stage4 |
8.816000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.18719520062427E-11 |
| Normal-vs-AfricanAmerican |
4.823100E-03 |
| Normal-vs-Asian |
4.06390000000645E-05 |
| Caucasian-vs-AfricanAmerican |
1.306040E-01 |
| Caucasian-vs-Asian |
3.696800E-01 |
| AfricanAmerican-vs-Asian |
4.629600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2818002215198E-10 |
| Normal-vs-Female |
8.82419692871395E-11 |
| Male-vs-Female |
4.269000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.63030000002829E-08 |
| Normal-vs-Age(41-60Yrs) |
5.2486004431529E-10 |
| Normal-vs-Age(61-80Yrs) |
3.67428309999696E-12 |
| Normal-vs-Age(81-100Yrs) |
2.319200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.590200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.737200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.489800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.732100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.873800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.129400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.202700E-03 |
| Classical-VS-Follicular |
1.378980E-04 |
| Classical-VS-Other |
8.867600E-01 |
| Classical-VS-Normal |
8.37000000419863E-08 |
| Tall-VS-Follicular |
1.581570E-01 |
| Tall-VS-Other |
6.557400E-01 |
| Tall-VS-Normal |
5.83380010965584E-10 |
| Follicular-VS-Other |
3.077400E-01 |
| Follicular-VS-Normal |
7.94775356638411E-12 |
| Other-VS-Normal |
1.683420E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.58859616969676E-11 |
| Normal-vs-N1 |
6.95179469545337E-11 |
| N0-vs-N1 |
7.661900E-02 |
|
|
